Trial Outcomes & Findings for Peppermint Oil for Urinary Retention (NCT NCT05259800)
NCT ID: NCT05259800
Last Updated: 2025-08-29
Results Overview
Urinary retention defined as: * More than 6 hours after delivery or foley catheter removal without being able to spontaneously void * Symptomatic urinary retention without being able to spontaneously void * Change in fundal height or position without being able to spontaneously void More than 6 hours after delivery or foley catheter removal without voiding spontaneously; symptomatic urinary retention without being able to spontaneously void; or change in fundal height or position without being able to spontaneously void Resolution of urinary retention will be achieved if patient spontaneously voids within 10 minutes after exposure to oil
TERMINATED
NA
17 participants
10 minutes
2025-08-29
Participant Flow
Participant milestones
| Measure |
Peppermint Oil
Subjects will be exposed to vapor of peppermint oil
Peppermint oil vapors: Subjects will be exposed to vapor of peppermint oil
|
Placebo
Subjects will be exposed to vapor of placebo (mineral oil)
Mineral Oil: Subjects will be exposed to vapor of placebo (mineral oil)
|
|---|---|---|
|
Overall Study
STARTED
|
10
|
7
|
|
Overall Study
COMPLETED
|
10
|
7
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
Peppermint Oil
n=10 Participants
Subjects will be exposed to vapor of peppermint oil
|
Placebo
n=7 Participants
Subjects will be exposed to vapor of placebo (mineral oil)
|
Total
n=17 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=10 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=17 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
10 Participants
n=10 Participants
|
7 Participants
n=7 Participants
|
17 Participants
n=17 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=10 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=17 Participants
|
|
Sex: Female, Male
Female
|
10 Participants
n=10 Participants
|
7 Participants
n=7 Participants
|
17 Participants
n=17 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=10 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=17 Participants
|
|
Race and Ethnicity Not Collected
|
—
|
—
|
0 Participants
Race and Ethnicity were not collected from any participant.
|
PRIMARY outcome
Timeframe: 10 minutesUrinary retention defined as: * More than 6 hours after delivery or foley catheter removal without being able to spontaneously void * Symptomatic urinary retention without being able to spontaneously void * Change in fundal height or position without being able to spontaneously void More than 6 hours after delivery or foley catheter removal without voiding spontaneously; symptomatic urinary retention without being able to spontaneously void; or change in fundal height or position without being able to spontaneously void Resolution of urinary retention will be achieved if patient spontaneously voids within 10 minutes after exposure to oil
Outcome measures
| Measure |
Peppermint Oil
n=10 Participants
Subjects will be exposed to vapor of peppermint oil
|
Placebo
n=7 Participants
Subjects will be exposed to vapor of placebo (mineral oil)
|
|---|---|---|
|
Percent of Patients With Urinary Retention Resolved
|
3 Participants
|
1 Participants
|
SECONDARY outcome
Timeframe: 1 hourMinutes until participant spontaneously voids
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 1 hourVolume of urine when participant spontaneously voids
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 1 hourWhether participant requires urinary catheterization or not
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 1 hourPatient rated satisfaction
Outcome measures
Outcome data not reported
Adverse Events
Peppermint Oil
Placebo
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place